Bionano Genomics Inc (NASDAQ:BNGO)
| 3.04 Delayed Data As of Sep 29 |  +0.135 / +4.66%Today’s Change | 2.79 Today|||52-Week Range 30.10 | -79.21% Year-to-Date |
Latest BNGO News | Press Releases
| Bionano Genomics, Inc. (BNGO) Upgraded to Buy: Here's What You Should Know Sep 21 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 2.90 |
| Today’s open | 2.97 |
| Day’s range | 2.95 - 3.07 |
| Volume | 16,412 |
| Average volume (3 months) | 1,018,391 |
| Market cap | $107.1M |
Data as of 4:00pm ET, 09/29/2023
Growth & Valuation
| Earnings growth (last year) | -75.19% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +54.62% |
| P/E ratio | NM |
| Price/Sales | 15.19 |
| Price/Book | 0.36 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARMPArmata Pharmaceutica... | +0.05 | +1.77% |
| CUECue Biopharma Inc | -0.03 | -1.29% |
| OCGNOcugen Inc | +0.00 | +0.99% |
| ANIXAnixa Biosciences In... | +0.06 | +1.87% |
Data as of 4:00pm ET, 09/29/2023
Financials
| Next reporting date | November 9, 2023 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $27.8M |
| Annual profit (last year) | -$132.6M |
| Net profit margin | -476.93% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
